Clinical Trials on Brain Diseases, Metabolic, Inborn
Total 87345 results
-
Yassin Abdelghaffar Charity Center for Liver Disease...Society of Friends of Liver Patients in the Arab World (SLPAW)RecruitingHereditary Tyrosinemia, Type IEgypt
-
University of Missouri-ColumbiaCompleted
-
University Hospital, ToursCompletedPhenylketonuriaFrance
-
Emory UniversityPatient-Centered Outcomes Research InstituteCompleted
-
Cycle Pharmaceuticals Ltd.ParexelCompletedHereditary Tyrosinemia, Type ISouth Africa
-
University of ZurichCompletedPhenylketonuria (PKU) and HyperphenylalaninemiaSwitzerland
-
Swedish Orphan BiovitrumCompletedHereditary Tyrosinemia, Type IGermany, United Kingdom, France
-
Orphanetics Pharma Entwicklungs GmbHTerminatedPhenylalanine Hydroxylase Deficiencies
-
National Center for Research Resources (NCRR)University of TexasCompleted
-
ShireTerminated
-
TakedaCompleted
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseCanada, Russian Federation, Tunisia
-
ShireCompleted
-
PfizerCompletedGaucher DiseaseUnited Kingdom, Canada, Israel, United States, Australia, Spain
-
PfizerCompletedGaucher DiseaseChile, United Kingdom, Canada, Spain, Israel, United States, Australia, South Africa
-
PfizerCompletedGaucher DiseaseIsrael, Paraguay, South Africa
-
Yasmeen Abd Elbaset HamzaaUnknownGaucher Disease
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States, Sweden, India, Netherlands, Austria, Japan, China, Serbia, France, Croatia, Australia, Portugal, Canada, Brazil, Greece, Romania, Russian Federation
-
ISU Abxis Co., Ltd.Completed
-
Ultragenyx Pharmaceutical IncCompletedOrnithine Transcarbamylase DeficiencyUnited States
-
Horizon Therapeutics, LLCCompletedUrea Cycle DisordersUnited States, Canada
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedUrea Cycle DisordersUnited States, Canada
-
Aeglea BiotherapeuticsTerminatedArginase I Deficiency | HyperargininemiaCanada
-
Aeglea BiotherapeuticsCompletedArginase I Deficiency | HyperargininemiaUnited States, Italy, Canada, France, United Kingdom, Austria, Germany
-
Children's National Research InstitutePatient-Centered Outcomes Research Institute; Eunice Kennedy Shriver National... and other collaboratorsCompleted
-
Vitaflo International, LtdActive, not recruiting
-
Cycle Pharmaceuticals Ltd.ParexelCompletedHereditary Tyrosinemia, Type ISouth Africa
-
Swedish Orphan BiovitrumCompletedEfficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1 (HT-1)Hereditary Tyrosinemia, Type IBelgium, Denmark, France, Germany, Sweden
-
Emma Marie Caroline SlackUniversity Children's HospitalCompletedInborn Errors of Metabolism | Propionic Aciduria | Methylmalonic Aciduria | Urea Cycle DisorderSwitzerland
-
CENTOGENE GmbH RostockWithdrawnMetabolic Disorders | Tyrosinosis | Hepatorenal Tyrosinemia | Fumarylacetoacetase Deficiency | Fah DeficiencyGermany, Sri Lanka, India
-
Istanbul University - Cerrahpasa (IUC)CompletedUrea Cycle Disorder | Lysinuric Protein IntoleranceTurkey
-
National Institute of Neurological Disorders and...Completed
-
University of GlasgowCompletedPhenylketonuria (PKU)United Kingdom
-
University of WashingtonCompleted
-
National Center for Research Resources (NCRR)University of MichiganCompletedTyrosinemia, Type I
-
University of MinnesotaRecruitingGaucher Disease, Type 3United States
-
TakedaActive, not recruiting
-
Shaare Zedek Medical CenterShireCompletedGaucher Disease, Type 1
-
Shaare Zedek Medical CenterPfizerCompletedGaucher Disease, Type 1
-
National Taiwan University HospitalSanofiCompleted
-
ShireCompletedGaucher Disease, Type 1Israel, Paraguay, Argentina, Russian Federation, Tunisia
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
PfizerWithdrawnType 1 Gaucher DiseaseUnited States
-
National Taiwan University HospitalActelionUnknown
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
National Institute of Neurological Disorders and...CompletedType 2 Gaucher DiseaseUnited States
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States